Keego Harbor, Michigan – Health Enhancement Products Incorporated a biotech firm from Michigan that investigates bioactive compounds that are extracted from culturing of algae, announce that they are in the process of a corporate name alteration.
Their new corporate identity will be ZIVO Bioscience Incorporated and will begin trading their new ticker symbol (ZIVO.QB) starting November 10 this year. The change will represent a new milestone in their two-plus transition to becoming a biotech business where their revenues are likely to be derived from partnership and licensing agreements.
The planned corporate name alteration was explained by Andrew Dahl, the company’s CEO, is both a practical and symbolic change. He added that it basically shows a clear break from the past which reflects their real efforts that lasted for 2 and a half years in trying to transform their company into a more viable R&D enterprise that boasts with great potential in medical and nutritional applications.
Since the beginning of the year 2012, the company had engaged in aggressive studies and validation programs that aim to prove the effectiveness of their natural products when it comes to various urgent care applications, like canine joint health and effectiveness, bovine udder health, and healthy cholesterol balance. Several studies already exited their pilot phases, and the Company is already looking to form a partnership with global companies in order to push their products forward further and supply every urgent care clinic with high quality products.
The corporate name alteration will not affect the company’s main goal of producing nutrition products and are ready to produce new protocols that are based on their developmental work with the collaboration of the Arizona Center for Algae Technology and Innovation, and the Provasoli-Guillard National Center for Marine Algae and Microbiota. Testing of such samples and production methods are needed for any product to be FDA registered.
The company aims to be able to provide all urgent care clinics and even individuals who are seeking urgent care near me with natural products that are proven to be very effective. The company is currently actively connecting with potential partners for production in order to develop better capacity and delivery.
Philip M. Rice II, the company’s Board Chair and CFO stated that their decision was based on market shares, margins, and revenues, and as they approach the time of executing licenses, the company hopes to provide more news on its progress. He added that they have deliberately held any announcements and expectations in check because they wanted to wait until they were 100% sure of going through with the corporate name alteration.
